HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-SEP-14 4WHZ TITLE DESIGN AND SYNTHESIS OF HIGHLY POTENT AND ISOFORM SELECTIVE JNK3 TITLE 2 INHIBITORS: SAR STUDIES ON AMINOPYRAZOLE DERIVATIVES COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 10,MAP KINASE P49 3F12,STRESS-ACTIVATED PROTEIN KINASE COMPND 5 1B,SAPK1B,STRESS-ACTIVATED PROTEIN KINASE JNK3,C-JUN N-TERMINAL COMPND 6 KINASE 3; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK10, JNK3, JNK3A, PRKM10, SAPK1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS JNK3, JNK2, JNK1, P38, KINASE INHIBITOR, PARKINSON DISEASE, ISOFORM- KEYWDS 2 SELECTIVITY, AMINOPYRAZOLE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 3 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.PARK,P.LOGRASSO REVDAT 3 27-DEC-23 4WHZ 1 SOURCE KEYWDS JRNL REMARK REVDAT 2 31-DEC-14 4WHZ 1 JRNL REVDAT 1 26-NOV-14 4WHZ 0 JRNL AUTH K.ZHENG,S.IQBAL,P.HERNANDEZ,H.PARK,P.V.LOGRASSO,Y.FENG JRNL TITL DESIGN AND SYNTHESIS OF HIGHLY POTENT AND ISOFORM SELECTIVE JRNL TITL 2 JNK3 INHIBITORS: SAR STUDIES ON AMINOPYRAZOLE DERIVATIVES. JRNL REF J.MED.CHEM. V. 57 10013 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 25393557 JRNL DOI 10.1021/JM501256Y REMARK 0 REMARK 0 : STATISTICS AT THE VERY BEGINNING WHEN NOTHING IS DONE YET REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 39375 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910 REMARK 3 FREE R VALUE TEST SET COUNT : 1933 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.84 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.23 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2869 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2227 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2703 REMARK 3 BIN R VALUE (WORKING SET) : 0.2220 REMARK 3 BIN FREE R VALUE : 0.2338 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.79 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 166 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2770 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 353 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.98 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.03860 REMARK 3 B22 (A**2) : 3.30800 REMARK 3 B33 (A**2) : 3.73070 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.258 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.127 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.120 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.119 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.115 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2903 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3951 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1043 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 71 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 406 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2903 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 363 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3545 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.42 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.63 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 9.3775 91.0104 130.6190 REMARK 3 T TENSOR REMARK 3 T11: 0.0199 T22: -0.1076 REMARK 3 T33: -0.1135 T12: 0.0065 REMARK 3 T13: 0.0150 T23: 0.0054 REMARK 3 L TENSOR REMARK 3 L11: 0.3467 L22: 1.5773 REMARK 3 L33: 1.3432 L12: -0.0277 REMARK 3 L13: -0.1682 L23: -0.3039 REMARK 3 S TENSOR REMARK 3 S11: 0.0114 S12: 0.0089 S13: -0.0065 REMARK 3 S21: -0.1192 S22: -0.0485 S23: -0.1562 REMARK 3 S31: 0.0077 S32: 0.1020 S33: 0.0371 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4WHZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1000203857. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 31-JUL-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-G REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39652 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 59.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM TARTRATE PH 7.0, 20 % REMARK 280 PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.96000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.84500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.46500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.84500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.96000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.46500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 39 REMARK 465 SER A 40 REMARK 465 LYS A 41 REMARK 465 SER A 42 REMARK 465 LYS A 43 REMARK 465 VAL A 44 REMARK 465 ARG A 212 REMARK 465 THR A 213 REMARK 465 ALA A 214 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 GLN A 374 REMARK 465 ILE A 375 REMARK 465 TYR A 376 REMARK 465 ASP A 377 REMARK 465 LYS A 378 REMARK 465 GLN A 379 REMARK 465 LEU A 380 REMARK 465 ASP A 381 REMARK 465 GLU A 382 REMARK 465 SER A 401 REMARK 465 GLU A 402 REMARK 465 GLU A 403 REMARK 465 LYS A 404 REMARK 465 THR A 405 REMARK 465 LYS A 406 REMARK 465 ASN A 407 REMARK 465 GLY A 408 REMARK 465 VAL A 409 REMARK 465 VAL A 410 REMARK 465 LYS A 411 REMARK 465 GLY A 412 REMARK 465 GLN A 413 REMARK 465 PRO A 414 REMARK 465 SER A 415 REMARK 465 PRO A 416 REMARK 465 SER A 417 REMARK 465 GLY A 418 REMARK 465 ALA A 419 REMARK 465 ALA A 420 REMARK 465 VAL A 421 REMARK 465 ASN A 422 REMARK 465 SER A 423 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 285 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 74 -65.18 -158.79 REMARK 500 ARG A 97 59.48 39.87 REMARK 500 ASN A 119 83.21 -158.48 REMARK 500 GLN A 140 -56.37 -127.28 REMARK 500 ARG A 188 -10.60 71.70 REMARK 500 ASP A 321 -75.38 -65.24 REMARK 500 GLU A 369 42.50 -106.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 756 DISTANCE = 5.84 ANGSTROMS REMARK 525 HOH A 893 DISTANCE = 9.24 ANGSTROMS REMARK 525 HOH A 895 DISTANCE = 6.34 ANGSTROMS REMARK 525 HOH A 898 DISTANCE = 8.06 ANGSTROMS REMARK 525 HOH A 901 DISTANCE = 6.20 ANGSTROMS REMARK 525 HOH A 929 DISTANCE = 8.77 ANGSTROMS REMARK 525 HOH A 943 DISTANCE = 9.67 ANGSTROMS REMARK 525 HOH A 948 DISTANCE = 9.29 ANGSTROMS REMARK 525 HOH A 951 DISTANCE = 6.46 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3NL A 501 DBREF 4WHZ A 39 423 UNP P53779 MK10_HUMAN 39 423 SEQRES 1 A 385 MET SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER VAL SEQRES 2 A 385 GLU VAL GLY ASP SER THR PHE THR VAL LEU LYS ARG TYR SEQRES 3 A 385 GLN ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE SEQRES 4 A 385 VAL CYS ALA ALA TYR ASP ALA VAL LEU ASP ARG ASN VAL SEQRES 5 A 385 ALA ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR SEQRES 6 A 385 HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET LYS SEQRES 7 A 385 CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN VAL SEQRES 8 A 385 PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP VAL SEQRES 9 A 385 TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN SEQRES 10 A 385 VAL ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER TYR SEQRES 11 A 385 LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SEQRES 12 A 385 SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 385 ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP SEQRES 14 A 385 PHE GLY LEU ALA ARG THR ALA GLY THR SER PHE MET MET SEQRES 15 A 385 THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU SEQRES 16 A 385 VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP ILE SEQRES 17 A 385 TRP SER VAL GLY CYS ILE MET GLY GLU MET VAL ARG HIS SEQRES 18 A 385 LYS ILE LEU PHE PRO GLY ARG ASP TYR ILE ASP GLN TRP SEQRES 19 A 385 ASN LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO GLU SEQRES 20 A 385 PHE MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR VAL SEQRES 21 A 385 GLU ASN ARG PRO LYS TYR ALA GLY LEU THR PHE PRO LYS SEQRES 22 A 385 LEU PHE PRO ASP SER LEU PHE PRO ALA ASP SER GLU HIS SEQRES 23 A 385 ASN LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SER SEQRES 24 A 385 LYS MET LEU VAL ILE ASP PRO ALA LYS ARG ILE SER VAL SEQRES 25 A 385 ASP ASP ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP TYR SEQRES 26 A 385 ASP PRO ALA GLU VAL GLU ALA PRO PRO PRO GLN ILE TYR SEQRES 27 A 385 ASP LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU GLU SEQRES 28 A 385 TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASN SER GLU SEQRES 29 A 385 GLU LYS THR LYS ASN GLY VAL VAL LYS GLY GLN PRO SER SEQRES 30 A 385 PRO SER GLY ALA ALA VAL ASN SER HET 3NL A 501 58 HETNAM 3NL 3-(4-{[(2-CHLOROPHENYL)CARBAMOYL]AMINO}-1H-PYRAZOL-1- HETNAM 2 3NL YL)-N-{1-[(3S)-PYRROLIDIN-3-YL]-1H-PYRAZOL-4- HETNAM 3 3NL YL}BENZAMIDE FORMUL 2 3NL C24 H23 CL N8 O2 FORMUL 3 HOH *353(H2 O) HELIX 1 AA1 PRO A 98 GLN A 100 5 3 HELIX 2 AA2 ASN A 101 MET A 115 1 15 HELIX 3 AA3 LEU A 153 GLN A 158 1 6 HELIX 4 AA4 ASP A 162 ALA A 183 1 22 HELIX 5 AA5 LYS A 191 SER A 193 5 3 HELIX 6 AA6 ALA A 231 LEU A 236 1 6 HELIX 7 AA7 ASN A 243 HIS A 259 1 17 HELIX 8 AA8 ASP A 267 GLY A 280 1 14 HELIX 9 AA9 CYS A 283 LYS A 288 1 6 HELIX 10 AB1 GLN A 291 ASN A 300 1 10 HELIX 11 AB2 THR A 308 PHE A 313 1 6 HELIX 12 AB3 PRO A 314 PHE A 318 5 5 HELIX 13 AB4 SER A 322 LEU A 340 1 19 HELIX 14 AB5 SER A 349 GLN A 355 1 7 HELIX 15 AB6 HIS A 356 VAL A 361 1 6 HELIX 16 AB7 ASP A 364 GLU A 369 1 6 HELIX 17 AB8 THR A 386 ASN A 400 1 15 SHEET 1 AA1 2 PHE A 48 VAL A 53 0 SHEET 2 AA1 2 SER A 56 LEU A 61 -1 O PHE A 58 N VAL A 51 SHEET 1 AA2 5 TYR A 64 GLY A 71 0 SHEET 2 AA2 5 ILE A 77 ASP A 83 -1 O TYR A 82 N GLN A 65 SHEET 3 AA2 5 ARG A 88 SER A 96 -1 O ARG A 88 N ASP A 83 SHEET 4 AA2 5 ASP A 141 GLU A 147 -1 O VAL A 142 N LEU A 95 SHEET 5 AA2 5 ASN A 128 PHE A 130 -1 N PHE A 130 O TYR A 143 SHEET 1 AA3 3 ALA A 151 ASN A 152 0 SHEET 2 AA3 3 ILE A 195 VAL A 197 -1 O VAL A 197 N ALA A 151 SHEET 3 AA3 3 LEU A 203 ILE A 205 -1 O LYS A 204 N VAL A 196 SITE 1 AC1 15 ILE A 70 ASN A 89 ALA A 91 LYS A 93 SITE 2 AC1 15 ILE A 124 LEU A 144 MET A 146 LEU A 148 SITE 3 AC1 15 MET A 149 ASP A 150 LEU A 206 ASP A 267 SITE 4 AC1 15 HOH A 620 HOH A 710 HOH A 925 CRYST1 53.920 70.930 107.690 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018546 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014098 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009286 0.00000